COMP <GO>
BXC vs REZI // EV/EBITDA & P/E VALUATION
Bluelinx Holdings Inc. (NYSE) VS. Resideo Technologies Inc. (NYSE) • 15-METRIC TALLY: BXC 3
— REZI 7
▲ EV/EBITDA & P/E VALUATION LEADER: REZI
LAST: $78.26 (+4.47%) • MKT CAP: $615.1M
valuation
9.5x
LAST: $18.80 (+2.68%) • MKT CAP: $2.85B
valuation
7.6x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BXC VS. REZI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BXC | REZI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 15.30% | 29.40% | -14.10 | REZI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.90% | 8.80% | -3.90 | REZI | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 9.5x | 7.6x | +1.90 | REZI | /valuation <GO> |
| Free Cash Flow Yield | 5.34% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | 1.10% | 8.10% | -7.00 | REZI | /operating-margins <GO> |
| Net Profit Margin | 0.00% | -7.10% | +7.10 | BXC | /net-margins <GO> |
| Revenue Growth (YoY) | 0.00% | 10.50% | -10.50 | REZI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.44 | 1.72 | +1.72 | BXC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 4/9 | +2.00 | BXC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.5 | 59.9 | -2.36 | REZI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $615.1M | $2.85B | -$2.24B | REZI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BXC REV | REZI REV | BXC GROSS % | REZI GROSS % | BXC FCF | REZI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.95B | $7.47B | 15.3% | 29.4% | $32.9M | -$1.25B |
| FY 2024 | $2.95B | $6.76B | 16.6% | 28.1% | $45.1M | $364.0M |
| FY 2023 | $3.14B | $6.24B | — | — | $306.3M | $440.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BXC // BETA —
REZI // BETA —